Robert Hughes is a biotech entrepreneur and drug discovery expert, currently serving as an Entrepreneur in Residence at Atlas Venture. With a Ph. D. from Scripps Research, he was previously Chief Scientific Officer at Rectify Pharma and held key roles at Disarm Therapeutics and Boehringer Ingelheim. Colleagues describe him as bright, hardworking, and versatile.
He was a key member of the team at Disarm Therapeutics that delivered two development candidates, leading to the companys acquisition by Eli Lilly.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.